Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mustgrow Biologics Corp (OP: MGROF )

0.7865 +0.0206 (+2.69%)
Streaming Delayed Price Updated: 11:08 AM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,500
Open 0.7866
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.7659
Today's Range 0.7865 - 0.7866
52wk Range 0.5694 - 1.810
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Harbor Access Global SMID Cap Virtual Investor Conference: Presentations Now Available for Online Viewing
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire
Harbor Access Global SMID Investor Conference Agenda Announced for November 16th, 2023
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com 
From Virtual Investor Conferences
Via GlobeNewswire

Performance

YTD
-18.92%
-18.92%
1 Month
-14.35%
-14.35%
3 Month
-25.45%
-25.45%
6 Month
+17.56%
+17.56%
1 Year
-55.06%
-55.06%

More News

Read More
MustGrow and Global Partners Drive Biological Programs Forward
Via Newsfile
MustGrow Achieves Control of Root-Rot Disease Aphanomyces in Greenhouse Trials
Via Newsfile
Topics Intellectual Property
Exposures Intellectual Property
MustGrow Investor Webcast Today - Tuesday May 4th at 4:10pm ET
Via Newsfile
MustGrow Biologics and Univar Canada Ltd. Subsidiary NexusBioAg Announce Collaborative Field Trials Program in Canada
Via Newsfile
Topics Supply Chain
Exposures Supply Chain
MustGrow Highlights Positive Soil Health and Environmental Approach; Earth Day Investor Presentations
Via Newsfile
MustGrow Outlines Upcoming Investment Conferences
Via Newsfile
MustGrow Biologics Reports Positive Tobacco Field Trial Results Versus Synthetic Chemical "Chloropicrin"
Via Newsfile
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.